Tascom Co Ltd
336040
Company Profile
Business description
Tascom Co Ltd, formerly YIDOBIO Inc is a diabetes specialty company in Korea. The company develop cell therapy for the treatment of diabetes. It also manufactures and distributes diabetic supplies. The company's products include Blood glucose measurement system-acuraview, BD Ultra Fine PRO Pen Needle, Syringes-BD Ultrafine Syringes, Ido Sharp Container, and Ido safety lancet.
Contact
43 BanPo-daero 28-gil
5th Floor, i-SENS Building
SeoCho-gu
Seoul
KORT: +82 802232525
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
35
Stocks News & Analysis
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
stocks
Morningstar analyst reacts to Macquarie Group’s earnings
Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,966.70 | 3.20 | 0.04% |
| CAC 40 | 7,854.13 | 53.25 | 0.68% |
| DAX 40 | 24,204.99 | 234.63 | 0.98% |
| Dow JONES (US) | 44,701.36 | 136.20 | -0.30% |
| FTSE 100 | 9,141.12 | 59.68 | 0.66% |
| HKSE | 25,524.45 | 37.68 | -0.15% |
| NASDAQ | 21,156.95 | 21.63 | -0.10% |
| Nikkei 225 | 40,674.55 | 323.72 | -0.79% |
| NZX 50 Index | 12,936.41 | 25.67 | 0.20% |
| S&P 500 | 6,383.96 | 5.81 | -0.09% |
| S&P/ASX 200 | 8,704.60 | 6.90 | 0.08% |
| SSE Composite Index | 3,609.71 | 11.77 | 0.33% |